Developed by SB Communications Group, publisher of Diabetes and Primary Care, and fully sponsored by Novo Nordisk who had editorial input of the content.

As a GP or nurse working in primary care, you’ll be aware that the number of treatments available for glucose lowering in type 2 diabetes has increased markedly in recent years. What are the implications of this for day-to-day clinical practice? Taking a very practical and interactive approach, this programme aims to provide the answers in a single conference.

The day will feature onstage demonstrations on how to use GLP-1 receptor agonists and insulin therapies, case studies, interactive keypad voting and Q&A sessions in addition to traditional lecture-style presentations. Furthermore, with the upcoming revalidation requirements in mind, you will take away templates for your personal development portfolio and tools to consolidate and demonstrate the impact of your learning after the event.

Whether you have a specialist or general interest in diabetes, we hope you can join us at the venue nearest you, for what will be an exciting and rewarding educational activity.

UK/DB/0610/0141
June 2010